| Predicted Trait | |
| Reported Trait | Nonmucinous Epithelial Ovarian Cancer | 
| Mapped Trait(s) | ovarian carcinoma (EFO_0001075) | 
| Score Construction | |
| PGS Name | PRS22_OCstepwise | 
| Development Method | |
| Name | Stepwise method | 
| Parameters | NR | 
| Variants | |
| Original Genome Build | GRCh37 | 
| Number of Variants | 22 | 
| Effect Weight Type | beta | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000474 | 
| Citation (link to publication) | Hurwitz LM et al. JAMA Netw Open (2023) | 
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 63,702 individuals (100%) | 
| PGS Evaluation | |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | 
|---|---|---|---|
| Europe PMC: 35027648 | [ 
 | European | OCAC | 
| PGS Performance Metric ID (PPM) | PGS Sample Set ID (PSS) | Performance Source | Trait | PGS Effect Sizes (per SD change) | Classification Metrics | Other Metrics | Covariates Included in the Model | PGS Performance: Other Relevant Information | 
|---|---|---|---|---|---|---|---|---|
| PPM018518 | PSS011005| Multi-ancestry (including European)| 11,135 individuals | PGP000474 | Hurwitz LM et al. JAMA Netw Open (2023) | Reported Trait: Nonmucinous Epithelial Ovarian Cancer x aspirin use interaction | — | — | Odds ratio (OR, <median): 0.85 [0.7, 1.02] Odds ratio (OR, >=median): 0.86 [0.74, 1.01] | — | — | 
| PGS Sample Set ID (PSS) | Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS011005 | — | — | [ 
 | — | African American or Afro-Caribbean (Black) | — | OCAC | — | 
| PSS011005 | — | — | [ 
 | — | European | — | OCAC | — | 
| PSS011005 | — | — | [ 
 | — | Not reported | — | OCAC | — |